Mitchell Young Williams - 28 May 2025 Form 3 Insider Report for BioSig Technologies, Inc. (BSGM)

Reporting relationship: Chief Investment Officer
Issuer ticker: BSGM
Reported as of: 28 May 2025
Net transaction value: $0
SEC form: 3
Accepted by SEC: 09 Jun 2025, 18:31:07 UTC
Next SEC filing: 26 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Mitchell Young Williams

Key filing fact

Mitchell Young Williams filed Form 3 for BioSig Technologies, Inc. (BSGM) on 09 Jun 2025.

Key facts

This page summarizes Mitchell Young Williams's Form 3 filing for BioSig Technologies, Inc. (BSGM).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 Jun 2025, 18:31.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002071989 Primary reporting owner

Williams Mitchell Young

Relationship: Chief Investment Officer
Address: C/O BIOSIG TECHNOLOGIES, INC., 12424 WILSHIRE BLVD., STE. 745, LOS ANGELES
Signature: /s/ Mitchell Young Williams
Signature date: 09 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSGM holding

Restricted Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,000,000
Date: 28 May 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSGM holding Derivative

Exchangeable Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 28 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 937,382
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a restricted stock award of 1,000,000 shares of common stock, par value $0.001 per share (the "Common Stock") of BioSig Technologies, Inc. (the "Company") granted pursuant to the Company's 2023 Equity Incentive Plan. One-third of the shares (333,334 shares) will vest on the three-month anniversary of the grant date, subject to the reporting person's continued service with the Company through such date. The remaining two-thirds of the shares will vest in five subsequent quarterly installments-four equal installments of 133,333 shares each on each quarterly anniversary of the initial vesting date, and a final installment of 133,334 shares on the eighteen-month anniversary of the grant date-subject to continued service through each applicable vesting date.

Footnote F2

Represents the Common Stock that may be issued from time to time upon the exchange, retraction or redemption of exchangeable shares of BST Sub ULC, an unlimited liability company organized under the laws of the Province of British Columbia and a wholly-owned subsidiary of the Company (the "Exchangeable Shares"). Each Exchangeable Share may be exchanged for one share of Common Stock, subject to certain exceptions. The aggregate number of Exchangeable Shares that may be exchanged for Common Stock may not exceed 19.9% of the total outstanding Common Stock until such issuance is approved by the Company's stockholders. The Exchangeable Shares do not have an expiration date.